openPR Logo
Press release

Obsessive-Compulsive Disorder (OCD) Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ceruvia Lifesciences, Biohaven Pharmaceuticals, Octapharma

11-07-2023 06:33 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Obsessive-Compulsive Disorder (OCD) Pipeline Analysis

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Obsessive-Compulsive Disorder (OCD) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Obsessive-Compulsive Disorder (OCD) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Obsessive-Compulsive Disorder Therapeutics Market.

The report provides a detailed description of the Obsessive-Compulsive Disorder drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Obsessive-Compulsive Disorder Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Obsessive-Compulsive Disorder (OCD) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Obsessive-Compulsive Disorder therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Obsessive-Compulsive Disorder treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Obsessive-Compulsive Disorder drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Obsessive-Compulsive Disorder treatment market.

Learn More about the Clinical and Commercial Development Activities in the Obsessive-Compulsive Disorder Therapeutics Domain @
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Obsessive-Compulsive Disorder Therapeutics Analysis
Several major pharma and biotech companies are developing therapies for Obsessive Compulsive Disorder. Currently, Biohaven Pharmaceuticals is leading the therapeutics market with its Obsessive Compulsive Disorder drug candidates in the most advanced stage of clinical development.

Obsessive-Compulsive Disorder Companies in the Therapeutics Market Include:
• Ceruvia Lifesciences
• Biohaven Pharmaceuticals
• Octapharma
And Many Others

Emerging and Marketed Obsessive-Compulsive Disorder Therapies Covered in the Report Include:
• SYNP 101: Ceruvia Lifesciences
• Troriluzole: Biohaven Pharmaceuticals
• DSP-1181: Sumitomo Dainippon Pharma
And Many More

Get an in-depth Assessment of the Emerging Therapies and Obsessive-Compulsive Disorder Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Obsessive-Compulsive Disorder Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Obsessive Compulsive Disorder pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Obsessive-Compulsive Disorder Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Obsessive-Compulsive Disorder Current Treatment Patterns
4. Obsessive-Compulsive Disorder - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Obsessive-Compulsive Disorder Late-Stage Products (Phase-III)
7. Obsessive-Compulsive Disorder Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Obsessive-Compulsive Disorder Discontinued Products
13. Obsessive-Compulsive Disorder Product Profiles
14. Obsessive-Compulsive Disorder Companies
15. Obsessive-Compulsive Disorder Drugs
16. Dormant and Discontinued Products
17. Obsessive-Compulsive Disorder Unmet Needs
18. Obsessive-Compulsive Disorder Future Perspectives
19. Obsessive-Compulsive Disorder Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Pulmonology Devices Market
https://www.delveinsight.com/report-store/pulmonology-devices-market

Small Cell Lung Cancer Market
https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

Bronchiectasis Market
https://www.delveinsight.com/report-store/bronchiectasis-market

Lennox Gastaut Syndrome Market
https://www.delveinsight.com/report-store/lennox-gastaut-syndrome-market

Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market

Muscle Invasive Bladder cancer Market
https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market

Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market

Anesthesia Machines Market
https://www.delveinsight.com/report-store/anesthesia-workstation-machines-market

Secondary Myelofibrosis Market
https://www.delveinsight.com/report-store/secondary-myelofibrosis-market

Guillain-Barre Syndrome (GBS) Market
https://www.delveinsight.com/report-store/guillain-barre-syndrome-gbs-market

Hepatitis A Market
https://www.delveinsight.com/report-store/hepatitis-a-market

Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-market

Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market

Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report

Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market

Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market

Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market

Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market

Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market

Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market

Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market

Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market

Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market

Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market

Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market

Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market

Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market

Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market

Factor XA Inhibitor Market
https://www.delveinsight.com/report-store/factor-xa-inhibitor-market

Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market

Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market

Primary Progressive Multiple Sclerosis (PPMS) Market
https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market

Thalassemia Market
https://www.delveinsight.com/report-store/thalassemia-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Obsessive-Compulsive Disorder (OCD) Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ceruvia Lifesciences, Biohaven Pharmaceuticals, Octapharma here

News-ID: 3279555 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Disorder

Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate? The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope: Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031). Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition. ♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms